Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-03-30
1992-05-26
Elmore, Carolyn
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514336, 514342, 514345, 514353, 514357, 514444, 514445, 514447, 514438, 514585, 514586, 514587, 514596, 514598, 514824, 564 27, 564 28, 564 29, 564 26, 564 48, 564 52, 546261, 546265, 546284, 546291, C07C27534, C07C27528, A61K 3117
Patent
active
051168480
ABSTRACT:
Certain N-2,6-dialkyl- or N-2,6-dialkoxphenyl-N'-diarylalkylurea compounds are potent inhibitors of the enzyme acyl CoA:cholesterol acyltransferase (ACAT), and are thus useful agents for the treatment of hypercholesterolemia or atherosclerosis with urea and thiourea compounds.
REFERENCES:
patent: 2911393 (1959-11-01), Brooks et al.
patent: 3028391 (1962-04-01), Rorig
patent: 4387105 (1983-06-01), DeVries et al.
patent: 4387106 (1983-06-01), DeVries et al.
patent: 4397868 (1983-08-01), DeVries
patent: 4410697 (1983-10-01), Torok et al.
patent: 4473579 (1984-09-01), DeVries et al.
patent: 4623662 (1986-11-01), DeVries
Elmore Carolyn
Newtson Ruth H.
Warner-Lambert & Company
LandOfFree
N-(((2,6-disubstituted)phenyl)-N-diarylalkyl)ureas as antihyperl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(((2,6-disubstituted)phenyl)-N-diarylalkyl)ureas as antihyperl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(((2,6-disubstituted)phenyl)-N-diarylalkyl)ureas as antihyperl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-420038